Article R1342-3
…where appropriate, restrictions or special requirements for placing the substance or mixture on the market.
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 8321–8330 of 13025 articles for “Art. Euronext Harmonised Market Rules — derivatives”
…where appropriate, restrictions or special requirements for placing the substance or mixture on the market.
…necessary knowledge, skills and experience referred to inArticle L. 533-25 with regard to financial markets, legal and regulatory requirements applicable to the investment firm, its system of governan…
…lationship when their customer is a company whose securities are admitted to trading on a regulated market in France, in another Member State of the European Union, in another State party to the Agree…
…established are deemed to be covered by the compassionate prescribing framework. The holder of the marketing authorisation for the generic medicinal product or similar biological medicinal product or…
…cognition procedure or the decentralised procedure under the same conditions as those laid down for marketing authorisation in articles R. 5121-51 to R. 5121-51-7.
…o more than three active substances, the non-proprietary name(s) ; 2° The name of the holder of the marketing authorisation for the medicinal product or product; 3° The batch number; 4° The expiry dat…
The company marketing a medicinal product shall set up an advertising department within the meaning of article L. 5122-1, under the supervision of the pharmacist responsible, which shall ensure compli…
…ependence or abuse as defined in article R. 5132-97, may require control at certain stages of their marketing. The provisions of this sub-section applicable to each of these substances are laid down,…
…or that it has no undesirable effects; 2° Emphasises that the product or object has been granted a marketing authorisation; 3° refers to a recommendation issued by scientists, health professionals or…
…e itself as an importer or distributor for the in vitro diagnostic medical devices it places on the market. Importers are not required to declare themselves as distributors for the in vitro diagnostic…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More